An interventional study of My Grief in Prolonged Grief Disorder, sponsored by Uppsala University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-11.
Sponsored by Uppsala University · Not applicable, Interventional, and Supportive care
Bereaved parents are at increased risk of developing mental and physical health problems and bereavement is even associated with an increased risk of mortality, especially in mothers. Prolonged grief disorder (PGD) are persistent and intensive grief reactions which can persist for years. It is characterized by an intense and lasting yearning for the deceased, intense emotional pain, such as difficulty accepting the loss and an inability to experience positive mood. Parents are among the most vulnerable to develop PGD.
The goal is to increase the accessibility to evidence-based and cost-effective interventions for parents of children who have died of cancer, and thus facilitate the grieving process and decrease the risk for parents to develop long-term distress.
Specific aims are:
There is a lack of studies evaluating the effect of interventions for bereaved parents. Thus, there is a need for accessible interventions with documented efficacy for preventing or reducing negative mental health consequences after the loss of a child. Today, many individuals carry smartphones and these devices can be used to access self-help interventions aiming to improve both physical and mental health. Currently, there are an excess of apps available for smartphone users that assert that they help people with their physical or mental health. However, for most of these apps, there is a lack of empirical support, i.e., their efficacy is unknown. It is therefore important to evaluate mobile apps in scientific studies with rigorous designs. In addition, before conducting rigorous studies of novel psychosocial interventions, such as a mobile app, it is important to conduct more basic work evaluating development and feasibility of the intervention. One such self-help app, the PTSD Coach, has been evaluated in a randomized controlled trial conducted with traumatized participants recruited from the community, which found that access to the PTSD Coach app was associated with improvements in posttraumatic stress (PTS) symptoms, depression, and psychosocial functioning. The PTSD Coach app is based on cognitive behavioural therapy (CBT) principles and there is a growing body of evidence that elements of CBT are effective interventions for prolonged grief. Thus, an app targeting prolonged grief using elements of CBT could potentially be effective in improving the mental health in bereaved parents. To our knowledge no such app has been developed and evaluated. The Grief Coach app will be based on the smartphone app PTSD Coach. A Swedish version of the PTSD Coach has been developed and a pilot study has been conducted as well as an ongoing RCT. Consultant programmers at Uppsala University will develop the mobile app. The content of the app will be developed together with experts in the field of grief, inspired by other grief apps and CBT therapy manuals, to modify parts of the PTSD Coach app to grief.
The main aim of this study is to examine the effectiveness of the app My Grief as compared to a waiting list comparison in reducing symptoms of prolonged grief in bereaved parents. The primary hypothesis is that the parents in the intervention group will report decreased levels of prolonged grief symptoms after having used the app. A second aim is to examine the effect of the app on related mental health problems (posttraumatic stress symptoms, depression symptoms, quality of life) and cognitive behavioral variables putatively explaining the effect of CBT techniques (i.e., grief avoidance, grief rumination and negative grief cognitions). The secondary hypotheses are that the parents in the intervention group will report improved mental health (i.e., lower symptom levels of depression and posttraumatic stress, higher quality of life), and lower grief avoidance, grief rumination, negative grief-related cognitions. A third aim is to evaluate the feasibility of the app, including participant satisfaction, evaluation of the app's strengths and weaknesses, and adverse events.
Potential participants are identified using the Swedish Childhood Cancer Registry, the Cause of Death Registry, and the Swedish Population Register at the Swedish Tax Agency. By linking the Cause of Death Registry with the Swedish Childhood Cancer Registry, children diagnosed with a malignancy and who died due to the malignancy 1 to 10 years previously will be identified. Next, the children's parents/caregivers are identified through the Swedish Population Register and will be sent a letter with an invitation to participate in the study. Participants will complete a web based pre-assessment and then given access to the app for three months followed by a web based post-assessment and an interview via telephone regarding their experiences of using the app, with follow-ups att 6 and 12 months.
39 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.
This study's enrollment of 248 is above the median of 68 across 35 interventional studies indexed under Prolonged Grief Disorder.
Browse Prolonged Grief Disorder studies →Uppsala University is the lead sponsor of 381 studies on the registry; 84 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants will complete a web based pre-assessment and then given access to the app "My Grief" for three months followed by a web based post-assessment and an interview via telephone regarding their experiences of using the app, and follow-up questionnaires.
Other: My Grief
Participants will get access to the app after three months.
The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains four main sections: Learning, Self-assessment, Manage symptoms and Find support.
Change (from baseline) in Prolonged Grief Disorder-13 instrument, PG-13
13-item, self-rated measure of prolonged grief, total score ranges from 11 to 55, where a higher score indicates more symptoms
Time frame: 3, 6 and 12 months
Change (from baseline) in Posttraumatic stress disorder checklist for DSM-5, PCL-5
20-item, self-rated measure of posttraumatic stress disorder, total score range from 0-80, and a higher score indicates more symptoms
Time frame: 3, 6 and 12 months
Change (from baseline) in Patient Health Questionnaire, PHQ-9
9-item, self-rated measure of depression, total score ranges from 0-27, and a higher score indicates more symptoms
Time frame: 3, 6 and 12 months
Change (from baseline) in Utrecht Grief Rumination Scale, UGRS
15-item, self-rated measure of grief rumination, total scores range from 15 to 75, and a higher score indicates more grief rumination
Time frame: 3, 6 and 12 months
Change (from baseline) in Depressive and Anxious Avoidance in Prolonged Grief questionnaire
9-item, self-rated measure of avoidance, total score ranges from 9-72, and a higher score indicates more avoidance
Time frame: 3, 6 and 12 months
Change (from baseline) in 18 items from the Grief Cognitions Questionniare, GCQ
18-items, self-rated measure of grief cognitions, total score ranges from 0-90, and a higher score indicates more grief cognitions
Time frame: 3, 6 and 12 months
Change (from baseline) in Brunnsviken Brief Quality of Life Inventory, BBQ
12 items, self-rated measure of quality of life, covering six different life domains, Total score ranges from 0-96, higher scores indicates higher quality of life.
Time frame: 3, 6 and 12 months
Feasibility of the intervention and the application
Feasibility will be measured by "App Survey"
Time frame: 3 months
Acceptability of the intervention and the application
Acceptability will be measured by "App Survey"
Time frame: 3 months
Participants demographics
age, gender, time since loss, gender child, marital status, employment status, loss-related variables
Time frame: 0 months
Plan to share: Yes — All collected IPD
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uppsala University